Abstract
Background and purpose: The role of autophagy in response to ischemic stroke has been confusing with reports that both enhancement and inhibition of autophagy decrease infarct size and improve post-stroke outcomes. We sought to clarify this by comparing pharmacologic modulation of autophagy in two clinically relevant murine models of stroke.Methods: We used rapamycin to induce autophagy, and chloroquine to block completion of autophagy, by treating mice immediately after stroke and at 24 hours post-stroke in two different models; permanent Middle Cerebral Artery Ligation (MCAL), which does not allow for reperfusion of distal trunk of middle cerebral artery, and Embolic Clot Middle Cerebral Artery Occlusion (eMCAO) which allows for a slow reperfusion similar to that seen in most human stroke patients. Outcome measures at 48 hours post-stroke included infarct size analysis, behavioral assessment using Bederson neurological scoring, and survival.Results: Chloroquine treatment reduced the lesion size by approximately 30% and was significant only in the eMCAO model, where it also improved the neurological score, but did not increase survival. Rapamycin reduced lesion size by 44% and 50% in the MCAL and eMCAO models, respectively. Rapamycin also improved the neurological score to a greater degree than chloroquine and improved survival.Conclusions: While both inhibition and enhancement of autophagy by pharmacological intervention decreased lesion size and improved neurological scores, the enhancement with rapamycin showed a greater degree of improvement in outcomes as well as in survival. The protective action seen with chloroquine may be in part due to off-target effects on apoptosis separate from blocking lysosomal activity in autophagy. We conclude pharmacologic induction of autophagy is more advantageous than its blockade in physiologically-relevant permanent and slow reperfusion stroke models.
| Original language | English (US) |
|---|---|
| Article number | 8 |
| Journal | Experimental and Translational Stroke Medicine |
| Volume | 6 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jun 21 2014 |
Fingerprint
Keywords
- Autophagy
- Cerebral ischemia
- Chloroquine
- Embolic stroke
- Rapamycin
ASJC Scopus subject areas
- Neuroscience (miscellaneous)
- Cognitive Neuroscience
Cite this
Rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent MCAL, and embolic MCAO, murine models of stroke. / Buckley, Kathleen M.; Hess, Daniel L.; Sazonova, Irina Yurievna; Periyasamy Thandavan, Sudharsan; Barrett, John Ryan; Kirks, Russell; Grace, Harrison; Kondrikova, Galina; Johnson, Maribeth H; Hess, David C; Schoenlein, Patricia V; Hoda, MD Nasrul; Hill, William D.
In: Experimental and Translational Stroke Medicine, Vol. 6, No. 1, 8, 21.06.2014.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent MCAL, and embolic MCAO, murine models of stroke
AU - Buckley, Kathleen M.
AU - Hess, Daniel L.
AU - Sazonova, Irina Yurievna
AU - Periyasamy Thandavan, Sudharsan
AU - Barrett, John Ryan
AU - Kirks, Russell
AU - Grace, Harrison
AU - Kondrikova, Galina
AU - Johnson, Maribeth H
AU - Hess, David C
AU - Schoenlein, Patricia V
AU - Hoda, MD Nasrul
AU - Hill, William D
PY - 2014/6/21
Y1 - 2014/6/21
N2 - Background and purpose: The role of autophagy in response to ischemic stroke has been confusing with reports that both enhancement and inhibition of autophagy decrease infarct size and improve post-stroke outcomes. We sought to clarify this by comparing pharmacologic modulation of autophagy in two clinically relevant murine models of stroke.Methods: We used rapamycin to induce autophagy, and chloroquine to block completion of autophagy, by treating mice immediately after stroke and at 24 hours post-stroke in two different models; permanent Middle Cerebral Artery Ligation (MCAL), which does not allow for reperfusion of distal trunk of middle cerebral artery, and Embolic Clot Middle Cerebral Artery Occlusion (eMCAO) which allows for a slow reperfusion similar to that seen in most human stroke patients. Outcome measures at 48 hours post-stroke included infarct size analysis, behavioral assessment using Bederson neurological scoring, and survival.Results: Chloroquine treatment reduced the lesion size by approximately 30% and was significant only in the eMCAO model, where it also improved the neurological score, but did not increase survival. Rapamycin reduced lesion size by 44% and 50% in the MCAL and eMCAO models, respectively. Rapamycin also improved the neurological score to a greater degree than chloroquine and improved survival.Conclusions: While both inhibition and enhancement of autophagy by pharmacological intervention decreased lesion size and improved neurological scores, the enhancement with rapamycin showed a greater degree of improvement in outcomes as well as in survival. The protective action seen with chloroquine may be in part due to off-target effects on apoptosis separate from blocking lysosomal activity in autophagy. We conclude pharmacologic induction of autophagy is more advantageous than its blockade in physiologically-relevant permanent and slow reperfusion stroke models.
AB - Background and purpose: The role of autophagy in response to ischemic stroke has been confusing with reports that both enhancement and inhibition of autophagy decrease infarct size and improve post-stroke outcomes. We sought to clarify this by comparing pharmacologic modulation of autophagy in two clinically relevant murine models of stroke.Methods: We used rapamycin to induce autophagy, and chloroquine to block completion of autophagy, by treating mice immediately after stroke and at 24 hours post-stroke in two different models; permanent Middle Cerebral Artery Ligation (MCAL), which does not allow for reperfusion of distal trunk of middle cerebral artery, and Embolic Clot Middle Cerebral Artery Occlusion (eMCAO) which allows for a slow reperfusion similar to that seen in most human stroke patients. Outcome measures at 48 hours post-stroke included infarct size analysis, behavioral assessment using Bederson neurological scoring, and survival.Results: Chloroquine treatment reduced the lesion size by approximately 30% and was significant only in the eMCAO model, where it also improved the neurological score, but did not increase survival. Rapamycin reduced lesion size by 44% and 50% in the MCAL and eMCAO models, respectively. Rapamycin also improved the neurological score to a greater degree than chloroquine and improved survival.Conclusions: While both inhibition and enhancement of autophagy by pharmacological intervention decreased lesion size and improved neurological scores, the enhancement with rapamycin showed a greater degree of improvement in outcomes as well as in survival. The protective action seen with chloroquine may be in part due to off-target effects on apoptosis separate from blocking lysosomal activity in autophagy. We conclude pharmacologic induction of autophagy is more advantageous than its blockade in physiologically-relevant permanent and slow reperfusion stroke models.
KW - Autophagy
KW - Cerebral ischemia
KW - Chloroquine
KW - Embolic stroke
KW - Rapamycin
UR - http://www.scopus.com/inward/record.url?scp=84902722491&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84902722491&partnerID=8YFLogxK
U2 - 10.1186/2040-7378-6-8
DO - 10.1186/2040-7378-6-8
M3 - Article
VL - 6
JO - Experimental and Translational Stroke Medicine
JF - Experimental and Translational Stroke Medicine
SN - 2040-7378
IS - 1
M1 - 8
ER -